Observational Study
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Oct 16, 2021; 13(10): 518-528
Published online Oct 16, 2021. doi: 10.4253/wjge.v13.i10.518
Table 1 Patient’s characteristics
CharacteristicsTotal (%)H. pylori + (%) 47 (25.1%)H. pylori-(%) 140 (74.9%)P value
Age, yr0.580
< 5085 (45.5)23 (48.9)62 (44.3)
> 50102 (54.5)24 (51.1)78 (55.7)
Gender0.629
Male74 (39.5)20 (42.5)54 (38.6)
Female113 (60.5)27 (57.5)86 (61.4)
Symptoms
Epigastric pain83 (44.4)26 (55.3)57 (40.7)0.081
Heartburn40 (21.4)9 (19.1)31 (22.1)0.665
Previous treated H. pylori infection42 (22.5)17 (36.2)25 (17.9)0.009
Table 2 Endoscopic findings with standard focus high definition white light and association with Helicobacter pylori infection
Location
Feature
Patients
Sensitivity % (95%CI)
Specificity % (95%CI)
PPV % (95%CI)
NPV % (95%CI)
AUC % (95%CI)
Accuracy % (95%CI)
BodyErythema7580.9 (66.7-90.9)73.6 (65.5-80.7)50.7 (38.9-62.4)92.0 (85.3-62.4)0.77 (0.70-0.84)75.4 (68.6-81.4)
Erosion1610.6 (3.6-23.1)92.1 (86.4-96.0)31.3 (11.0-58.7)75.4 (68.3-81.7)0.51 (0.46-0.56)71.7 (64.6-78.0)
Exudate46.4 (1.3-17.5)99.3 (96.1-100)75.0 (19.4-99.4)76.0 (69.1-82.0)0.53 (0.49-0.56)75.9 (69.2-81.9)
Atrophy1519.1 (9.1-33.3)95.7 (90.9-98.4)60.0 (71.0-83.9)77.9 (71.0-83.9)0.57 (0.52-0.63)76.5 (69.7-82.3)
Nodularity76.4 (1.3-17.5)97.1 (92.8-99.2)42.9 (9.9-81.6)75.6 (68.6-81.6)0.52 (0.48-0.56)74.3 (67.4-80.4)
AntrumErythema8772.3 (57.4-84.4)62.1 (53.6-70.2)39.1 (28.8-50.1)87.0 (78.8-92.9)0.67 (0.60-0.75)64.7 (57.4-71.5)
Erosion3821.3 (10.7-35.7)80.0 (72.4-86.3)26.3 (13.4-43.1)75.2 (67.4-81.9)0.51 (0.44-0.57)65.2 (57.9-72.0)
Exudate12.1 (0.5-11.3)100 (97.4-100)100 (2.5-100)75.3 (68.4-81.3)0.51 (0.49-0.53)75.4 (68.6-81.4)
Atrophy1623.4 (12.3-38.0)96.4 (91.9-98.8)68.8 (41.3-89.0)78.9 (72.1-84.8)0.60 (0.54-0.66)78.1 (71.4-83.8)
Nodularity710.6 (3.5-23.1)98.6 (94.9-99.8)71.4 (29.0-96.3)76.7 (69.8-82.6)0.55 (0.50-0.59)76.5 (69.7-82.3)
Table 3 Association between classifications and Helicobacter pylori infection of the gastric body
RAC
Classification
Helicobacter pylori status (%)
Total (%)
Negative
Positive
RAC +
Type 199 (94.3)6.0 (5.7)105 (56.2)
RAC -
Type 235 (61.4)22 (38.6)57 (30.5)
Type 36 (33.3)12 (66.7)18 (9.6)
Type 40 (0.0)7 (100.0)7 (3.7)
Types 2, 3 and 441 (50)41 (50)82 (43.8)
Total140 (74.9)47 (25.1)187 (100)
Table 4 Association between regular arrangement of collecting venules and Helicobacter pylori infection in patients with previous Helicobacter pylori treatment
Classification
Helicobacter pylori status (%)
Total (%)
Negative
Positive
RAC +21 (91.3)2 (8.7)23 (54.8)
RAC -4 (21.1)15 (78.9)19 (45.2)
Total25 (59.5)17 (40.5)42 (100)
Table 5 Loss of regular arrangement of collecting venules with near focus high-definition examination in the gastric body and correlation with Helicobacter pylori infection
Loss of RACSensitivity% (95%CI)Specificity% (95%CI)PPV % (95%CI)NPV % (95%CI)AUC % (95%CI)Accuracy % (95%CI)
Overall (n = 187)87.2 (74.3-95.2)70.7 (62.4-78.1)50.0 (38.7-61.3)94.3 (88.0-97.9)0.79 (0.73-0.85)74.5 (67.6-80.5)
Patients without previous Helicobacter pylori treatment (n = 145)86.7 (69.3-96.2)67.8 (58.5-76.2)41.3 (29.0-54.4)95.1 (88.0-98.7)0.77 (0.69-0.85)71.7 (63.6-78.9)
Patients with previous Helicobacter pylori treatment (n = 42)88.2 (63.6-98.5)84.0 (63.9-95.5)78.9 (54.4-93.9)91.3 (72.0-98.9)0.86 (0.73-0.97)85.7 (71.5-94.6)
Table 6 Studies associating loss of regular arrangement of collecting venules with the presence of Helicobacter pylori
Ref.CountrynRAC +TechnologySensitivitySpecificityPPVNPV
Machado et al[16], 2008Brazil9960SD96.988.1--
Cho et al[15], 2013Korea617254S-HD93.389.192.90.6
Yagi et al[17], 2014Japan3826S-HD79527063
Garcés-Durán et al[14], 2019Spain14047S-HD10048.947.3100
Ebigbo et al[22], 2021German200-S-HD80.757.440.089.4
Glover et al[21], 2021United Kingdom153108S-HD78.464.340.090.7
Jang et al[18], 2020Korea115-NF + NBI86.584.184.188.3
Yagi et al[11], 2002Japan557161ME93.896.2--
Nakagawa et al[12], 2003Japan9223ME66.710010082.4
Anagnostopoulos et al[10], 2007United Kingdom9564ME100 92.783.8100
Yagi et al[17], 2014Japan4930ME + NBI91838886
This studyBrazil187105NF87.270.750.094.3